BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9131484)

  • 1. Overview of enzymes of drug metabolism.
    Meyer UA
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):449-59. PubMed ID: 9131484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human drug metabolizing cytochromes P450.
    Wrighton SA; VandenBranden M; Ring BJ
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):461-73. PubMed ID: 9131485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro techniques for studying drug metabolism.
    Guengerich FP
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):521-33. PubMed ID: 9131489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: genetic polymorphism of drug metabolizing enzymes in humans.
    Tanaka E
    J Clin Pharm Ther; 1999 Oct; 24(5):323-9. PubMed ID: 10583694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
    Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
    J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of xenobiotic metabolism in children: toxicological implications.
    Cresteil T
    Food Addit Contam; 1998; 15 Suppl():45-51. PubMed ID: 9602911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of drug-metabolizing enzymes: mechanisms and consequences.
    Okey AB; Roberts EA; Harper PA; Denison MS
    Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O; Yano Y
    Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
    Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
    Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
    Orrenius S; Thor H; Jernström B
    Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of polymorphic drug metabolism.
    Daly AK
    J Mol Med (Berl); 1995 Nov; 73(11):539-53. PubMed ID: 8751138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
    Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.
    Batt AM; Magdalou J; Vincent-Viry M; Ouzzine M; Fournel-Gigleux S; Galteau MM; Siest G
    Clin Chim Acta; 1994 May; 226(2):171-90. PubMed ID: 7923812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating human interindividual biotransformation variance in health risk assessment.
    Lipscomb JC; Kedderis GL
    Sci Total Environ; 2002 Apr; 288(1-2):13-21. PubMed ID: 12013540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.